drugset / Trial / NCT00856713
Clearance of NRL972 in Patients With Cirrhosis and in Healthy Volunteers
Non-randomizedParallel-groupOpen-labelDiagnostic
Summary
A study in healthy volunteers and patients with liver cirrhosis to assess the effects of age, gender, and stable liver disease on the clearance of cholyl-lysyl-fluorescein (NRL972)
Timeline
- Start
- 2006-03
- Primary completion
- 2006-08
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | FLUORESCEIN LISICOL | Diagnostic / imaging agent | 2 mg | Intravenous |